These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1400646)

  • 1. Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease.
    Duara R; Barker WW; Chang J; Yoshii F; Loewenstein DA; Pascal S
    J Cereb Blood Flow Metab; 1992 Nov; 12(6):927-34. PubMed ID: 1400646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
    Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
    J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data.
    Azari NP; Pettigrew KD; Schapiro MB; Haxby JV; Grady CL; Pietrini P; Salerno JA; Heston LL; Rapoport SI; Horwitz B
    J Cereb Blood Flow Metab; 1993 May; 13(3):438-47. PubMed ID: 8478402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution PET studies in Alzheimer's disease.
    Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
    Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
    Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E
    J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
    Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in Alzheimer's disease.
    Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
    Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET.
    Pietrini P; Alexander GE; Furey ML; Dani A; Mentis MJ; Horwitz B; Guazzelli M; Shapiro MB; Rapoport SI
    J Nucl Med; 2000 Apr; 41(4):575-83. PubMed ID: 10768555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
    Kuhl DE; Metter EJ; Riege WH
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():211-26. PubMed ID: 4023401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
    JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of cerebral glucose utilization in dementia.
    Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
    Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis.
    Minoshima S; Frey KA; Foster NL; Kuhl DE
    J Comput Assist Tomogr; 1995; 19(4):541-7. PubMed ID: 7622680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
    Kessler J; Herholz K; Grond M; Heiss WD
    Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
    Foster NL; VanDerSpek AF; Aldrich MS; Berent S; Hichwa RH; Sackellares JC; Gilman S; Agranoff BW
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):415-20. PubMed ID: 3497161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.